The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS)

Tae Nyun Kim, Man Sik Park, Eun Joo Lee, Hye Soo Chung, Hye-Jin Yoo, Hyun Joo Kang, Wook Song, Sei-Hyun Baik, Kyung Mook Choi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Advanced glycation end products (AGEs) are accumulated with aging in various tissues of humans. The soluble receptor for AGEs (sRAGE) exerts a protective role against the development of aging-related chronic disorders by neutralizing the action of AGEs. We investigated the implication of sRAGE on low muscle mass in Asian men and women. Methods: This cross-sectional study included a 390-participant, nondiabetic subcohort recruited within the framework of the Korean Sarcopenic Obesity Study, an ongoing prospective cohort study. Low muscle mass was defined based on the distribution of appendicular skeletal muscle mass divided by body mass index, as proposed by the Foundation for the National Institutes Sarcopenia Project. Results: Serum sRAGE levels were significantly lower in participants with low muscle mass than in participants without low muscle mass (0.76 [0.60-1.00] ng/mL vs 0.87 [0.67-1.15] ng/mL, P = .005). In age- and sex-adjusted correlation analyses, appendicular skeletal muscle mass divided by body mass index was associated with sRAGE (r = 0.109, P = .037). Furthermore, decreased circulating levels of sRAGE are independently associated with low muscle mass (odds ratio = 0.254, P = .002) after adjusting for confounding factors, including insulin resistance and inflammatory markers. Conclusions: The present study shows that a low circulating level of sRAGE may be an independent risk factor for the presence of low muscle mass.

Original languageEnglish
JournalDiabetes/Metabolism Research and Reviews
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Obesity
Muscles
Skeletal Muscle
Body Mass Index
Sarcopenia
Advanced Glycosylation End Products
Insulin Resistance
Advanced Glycosylation End Product-Specific Receptor
Cohort Studies
Cross-Sectional Studies
Odds Ratio
Prospective Studies
Serum

Keywords

  • Body composition
  • Low muscle mass
  • Sarcopenia
  • sRAGE

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE) : The Korean Sarcopenic Obesity Study (KSOS). / Kim, Tae Nyun; Park, Man Sik; Lee, Eun Joo; Chung, Hye Soo; Yoo, Hye-Jin; Kang, Hyun Joo; Song, Wook; Baik, Sei-Hyun; Choi, Kyung Mook.

In: Diabetes/Metabolism Research and Reviews, 01.01.2018.

Research output: Contribution to journalArticle

@article{8209b15768564383bb40e73f29738f6f,
title = "The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS)",
abstract = "Background: Advanced glycation end products (AGEs) are accumulated with aging in various tissues of humans. The soluble receptor for AGEs (sRAGE) exerts a protective role against the development of aging-related chronic disorders by neutralizing the action of AGEs. We investigated the implication of sRAGE on low muscle mass in Asian men and women. Methods: This cross-sectional study included a 390-participant, nondiabetic subcohort recruited within the framework of the Korean Sarcopenic Obesity Study, an ongoing prospective cohort study. Low muscle mass was defined based on the distribution of appendicular skeletal muscle mass divided by body mass index, as proposed by the Foundation for the National Institutes Sarcopenia Project. Results: Serum sRAGE levels were significantly lower in participants with low muscle mass than in participants without low muscle mass (0.76 [0.60-1.00] ng/mL vs 0.87 [0.67-1.15] ng/mL, P = .005). In age- and sex-adjusted correlation analyses, appendicular skeletal muscle mass divided by body mass index was associated with sRAGE (r = 0.109, P = .037). Furthermore, decreased circulating levels of sRAGE are independently associated with low muscle mass (odds ratio = 0.254, P = .002) after adjusting for confounding factors, including insulin resistance and inflammatory markers. Conclusions: The present study shows that a low circulating level of sRAGE may be an independent risk factor for the presence of low muscle mass.",
keywords = "Body composition, Low muscle mass, Sarcopenia, sRAGE",
author = "Kim, {Tae Nyun} and Park, {Man Sik} and Lee, {Eun Joo} and Chung, {Hye Soo} and Hye-Jin Yoo and Kang, {Hyun Joo} and Wook Song and Sei-Hyun Baik and Choi, {Kyung Mook}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/dmrr.2974",
language = "English",
journal = "Diabetes/Metabolism Research and Reviews",
issn = "1520-7552",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE)

T2 - The Korean Sarcopenic Obesity Study (KSOS)

AU - Kim, Tae Nyun

AU - Park, Man Sik

AU - Lee, Eun Joo

AU - Chung, Hye Soo

AU - Yoo, Hye-Jin

AU - Kang, Hyun Joo

AU - Song, Wook

AU - Baik, Sei-Hyun

AU - Choi, Kyung Mook

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Advanced glycation end products (AGEs) are accumulated with aging in various tissues of humans. The soluble receptor for AGEs (sRAGE) exerts a protective role against the development of aging-related chronic disorders by neutralizing the action of AGEs. We investigated the implication of sRAGE on low muscle mass in Asian men and women. Methods: This cross-sectional study included a 390-participant, nondiabetic subcohort recruited within the framework of the Korean Sarcopenic Obesity Study, an ongoing prospective cohort study. Low muscle mass was defined based on the distribution of appendicular skeletal muscle mass divided by body mass index, as proposed by the Foundation for the National Institutes Sarcopenia Project. Results: Serum sRAGE levels were significantly lower in participants with low muscle mass than in participants without low muscle mass (0.76 [0.60-1.00] ng/mL vs 0.87 [0.67-1.15] ng/mL, P = .005). In age- and sex-adjusted correlation analyses, appendicular skeletal muscle mass divided by body mass index was associated with sRAGE (r = 0.109, P = .037). Furthermore, decreased circulating levels of sRAGE are independently associated with low muscle mass (odds ratio = 0.254, P = .002) after adjusting for confounding factors, including insulin resistance and inflammatory markers. Conclusions: The present study shows that a low circulating level of sRAGE may be an independent risk factor for the presence of low muscle mass.

AB - Background: Advanced glycation end products (AGEs) are accumulated with aging in various tissues of humans. The soluble receptor for AGEs (sRAGE) exerts a protective role against the development of aging-related chronic disorders by neutralizing the action of AGEs. We investigated the implication of sRAGE on low muscle mass in Asian men and women. Methods: This cross-sectional study included a 390-participant, nondiabetic subcohort recruited within the framework of the Korean Sarcopenic Obesity Study, an ongoing prospective cohort study. Low muscle mass was defined based on the distribution of appendicular skeletal muscle mass divided by body mass index, as proposed by the Foundation for the National Institutes Sarcopenia Project. Results: Serum sRAGE levels were significantly lower in participants with low muscle mass than in participants without low muscle mass (0.76 [0.60-1.00] ng/mL vs 0.87 [0.67-1.15] ng/mL, P = .005). In age- and sex-adjusted correlation analyses, appendicular skeletal muscle mass divided by body mass index was associated with sRAGE (r = 0.109, P = .037). Furthermore, decreased circulating levels of sRAGE are independently associated with low muscle mass (odds ratio = 0.254, P = .002) after adjusting for confounding factors, including insulin resistance and inflammatory markers. Conclusions: The present study shows that a low circulating level of sRAGE may be an independent risk factor for the presence of low muscle mass.

KW - Body composition

KW - Low muscle mass

KW - Sarcopenia

KW - sRAGE

UR - http://www.scopus.com/inward/record.url?scp=85041100898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041100898&partnerID=8YFLogxK

U2 - 10.1002/dmrr.2974

DO - 10.1002/dmrr.2974

M3 - Article

C2 - 29271076

AN - SCOPUS:85041100898

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

ER -